What is Crinetics Pharmaceuticals's net change in cash?

Crinetics Pharmaceuticals (CRNX) reported net change in cash of $12.81M in Q1 2026.

How has Crinetics Pharmaceuticals's net change in cash changed year-over-year?

Crinetics Pharmaceuticals's net change in cash increased by 107.5% year-over-year, from -$169.98M to $12.81M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Crinetics Pharmaceuticals CRNX Net Change in Cash

Net Change in Cash at other companies

Neurocrine BiosciencesNBIX

-$446.5M-1,048%

Corcept TherapeuticsCORT

-$11.76M+68.9%

Viking TherapeuticsVKTX

-$47.71M-524%

Catalyst PharmaceuticalCPRX

$46.69M-26.0%

Ultragenyx PharmaceuticalRARE

-$247M-449%

United TherapeuticsUTHR

-$277.4M-237%

Other financials

Income statement

See full

Revenue$10.7M+2,873%

Gross profit$10.5M+2,818%

Operating income-$140.4M-26.0%

Net income-$127.8M-32.1%

EPS (diluted)-$1.23-18.3%

Balance sheet

See full

Cash & equivalents$115.1M+20.1%

Total debt$47.9M-5.8%

Total equity$1.3B+2.1%

Total assets$1.4B+2.9%

Cash flow

See full

Operating cash flow-$124.7M-41.0%

CapEx$820.0K-33.8%

Free cash flow-$125.5M-40.0%

Valuation

See full

Market cap$3.79B+21.9%

Profitability

See full

Gross margin150%-15.6pp

Operating margin-3,020.3%-1,463pp

Net margin-2,747.2%-1,328pp

FCF margin-2,321.7%-1,122pp

Returns & leverage

See full

Return on equity-39.2%+14.5pp

Debt / equity0×0.0×

Current ratio18.6×-3.9×

Where this comes from

Reported directly by Crinetics Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect.

The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Crinetics Pharmaceuticals's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Crinetics Pharmaceuticals's net change in cash?: Crinetics Pharmaceuticals (CRNX) reported net change in cash of $12.81M in Q1 2026.
How has Crinetics Pharmaceuticals's net change in cash changed year-over-year?: Crinetics Pharmaceuticals's net change in cash increased by 107.5% year-over-year, from -$169.98M to $12.81M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.